# Income Opportunity Realty Investors Inc: financial statements, quarterly

IOR · NYSE · CIK 949961 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ior.md) · [Financials](/companies/ior/financials.md) · [Filings](/companies/ior/filings.md) · [Insiders](/companies/ior/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ior/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(437)](/filings/0001999371-25-002901.md) | [(30.0)](/filings/0001999371-25-002901.md) | [(95.0)](/filings/0001999371-26-005688.md) | [(114)](/filings/0001999371-26-005688.md) | [(97.0)](/filings/0001999371-26-005688.md) | [(106)](/filings/0001999371-26-005688.md) | [(95.0)](/filings/0001999371-26-010171.md) | [(97.0)](/filings/0001999371-26-017248.md) | [(90.0)](/filings/0001999371-26-005688.md) | [(101)](/filings/0001999371-26-005688.md) | [(97.0)](/filings/0001999371-26-010171.md) | [(97.0)](/filings/0001999371-26-017248.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [436](/filings/0001999371-24-014339.md) | [406 d](/filings/0001999371-26-005688.md) | [313](/filings/0001999371-25-005694.md) | [309](/filings/0001999371-25-010788.md) | [319](/filings/0001999371-25-017076.md) | [295 d](/filings/0001999371-26-005688.md) | [263](/filings/0001999371-26-010171.md) | [264](/filings/0001999371-26-017248.md) | [274](/filings/0001999371-25-017076.md) | [260 d](/filings/0001999371-26-005688.md) | [269](/filings/0001999371-26-010171.md) | [187](/filings/0001999371-26-017248.md) |
| Net income | $k | [1,643](/filings/0001999371-25-002901.md) | [2,474](/filings/0001999371-25-002901.md) | [1,178](/filings/0001999371-26-005688.md) | [1,162](/filings/0001999371-26-005688.md) | [1,198](/filings/0001999371-26-005688.md) | [1,113](/filings/0001999371-26-005688.md) | [989](/filings/0001999371-26-010171.md) | [994](/filings/0001999371-26-017248.md) | [1,031](/filings/0001999371-26-005688.md) | [976](/filings/0001999371-26-005688.md) | [1,010](/filings/0001999371-26-010171.md) | [705](/filings/0001999371-26-017248.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001999371-25-002901.md) | [0.60](/filings/0001999371-25-002901.md) | [0.29](/filings/0001999371-26-005688.md) | [0.28](/filings/0001999371-26-005688.md) | [0.29](/filings/0001999371-26-005688.md) | [0.27](/filings/0001999371-26-005688.md) | [0.24](/filings/0001999371-26-010171.md) | [0.24](/filings/0001999371-26-017248.md) | [0.25](/filings/0001999371-26-005688.md) | [0.25](/filings/0001999371-26-005688.md) | [0.25](/filings/0001999371-26-010171.md) | [0.17](/filings/0001999371-26-017248.md) |
| Basic EPS | $ per share | [0.39](/filings/0001999371-25-002901.md) | [0.60](/filings/0001999371-25-002901.md) | [0.29](/filings/0001999371-26-005688.md) | [0.28](/filings/0001999371-26-005688.md) | [0.29](/filings/0001999371-26-005688.md) | [0.27](/filings/0001999371-26-005688.md) | [0.24](/filings/0001999371-26-010171.md) | [0.24](/filings/0001999371-26-017248.md) | [0.25](/filings/0001999371-26-005688.md) | [0.25](/filings/0001999371-26-005688.md) | [0.25](/filings/0001999371-26-010171.md) | [0.17](/filings/0001999371-26-017248.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001999371-23-000059.md) | [0.1](/filings/0001999371-25-002901.md) | [0.0](/filings/0001999371-24-005847.md) | [0.0](/filings/0001999371-24-009758.md) | [0.0](/filings/0001999371-24-014339.md) | [0.0](/filings/0001999371-26-005688.md) | [0.2](/filings/0001999371-25-005694.md) | [0.1](/filings/0001999371-25-010788.md) | [0.0](/filings/0001999371-25-017076.md) | [0.0](/filings/0001999371-26-017248.md) | [0.0](/filings/0001999371-26-010171.md) | [0.0](/filings/0001999371-26-017248.md) |
| Current assets | $m | [105](/filings/0001999371-23-000059.md) | [107](/filings/0001999371-25-002901.md) | [107](/filings/0001999371-24-005847.md) | [109](/filings/0001999371-24-009758.md) | [110](/filings/0001999371-24-014339.md) | [111](/filings/0001999371-26-005688.md) | [112](/filings/0001999371-25-005694.md) | [113](/filings/0001999371-25-010788.md) | [114](/filings/0001999371-25-017076.md) | [115](/filings/0001999371-26-017248.md) | [116](/filings/0001999371-26-010171.md) | [117](/filings/0001999371-26-017248.md) |
| Total assets | $m | [117](/filings/0001999371-23-000059.md) | [118](/filings/0001999371-25-002901.md) | [119](/filings/0001999371-24-005847.md) | [120](/filings/0001999371-24-009758.md) | [121](/filings/0001999371-24-014339.md) | [122](/filings/0001999371-26-005688.md) | [123](/filings/0001999371-25-005694.md) | [124](/filings/0001999371-25-010788.md) | [125](/filings/0001999371-25-017076.md) | [126](/filings/0001999371-26-017248.md) | [127](/filings/0001999371-26-010171.md) | [128](/filings/0001999371-26-017248.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [117](/filings/0001999371-24-014339.md) | [118](/filings/0001999371-26-005688.md) | [119](/filings/0001999371-25-010788.md) | [120](/filings/0001999371-25-017076.md) | [121](/filings/0001999371-25-017076.md) | [122](/filings/0001999371-26-017248.md) | [123](/filings/0001999371-26-017248.md) | [124](/filings/0001999371-26-017248.md) | [125](/filings/0001999371-25-017076.md) | [126](/filings/0001999371-26-017248.md) | [127](/filings/0001999371-26-017248.md) | [128](/filings/0001999371-26-017248.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Total liabilities: not reported
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [10.0 d](/filings/0001999371-24-014339.md) | [967 d](/filings/0001999371-26-005688.md) | [552](/filings/0001999371-25-005694.md) | [(20.0) d](/filings/0001999371-25-010788.md) | [186 d](/filings/0001999371-25-017076.md) | [(5.0) d](/filings/0001999371-26-005688.md) | [147](/filings/0001999371-26-010171.md) | [(45.0) d](/filings/0001999371-26-017248.md) | [(179) d](/filings/0001999371-25-017076.md) | [0.0 d](/filings/0001999371-26-005688.md) | [(114)](/filings/0001999371-26-010171.md) | [25.0 d](/filings/0001999371-26-017248.md) |
| Share repurchases | $k | not reported | not reported | [587](/filings/0001999371-25-005694.md) | [0.0 d](/filings/0001999371-25-010788.md) | [215 d](/filings/0001999371-25-017076.md) | [0.0 d](/filings/0001999371-26-005688.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,168](/filings/0001999371-23-000059.md) | [4,168](/filings/0001999371-24-005847.md) | [4,168](/filings/0001999371-24-009758.md) | [4,168](/filings/0001999371-24-014339.md) | [4,107](/filings/0001999371-25-005694.md) | [4,107](/filings/0001999371-25-010788.md) | [4,070](/filings/0001999371-25-017076.md) | [4,066](/filings/0001999371-26-010171.md) | [4,066](/filings/0001999371-26-017248.md) | [4,066](/filings/0001999371-25-017076.md) | [4,066](/filings/0001999371-26-010171.md) | [4,066](/filings/0001999371-26-017248.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,066,178 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001999371-26-017248.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.